Cosmetic composition for preventing skin aging comprising extracts of metasequoia glyptostroboides as active ingredient
The cosmetic composition with Metasequoia Glyptostroboides, Centella Asiatica, Ganoderma Lucidum, and Saussurea grandifolia extracts addresses the challenge of wrinkle formation by inhibiting collagen-degrading enzymes and promoting collagen biosynthesis, offering an effective wrinkle improvement solution.
Patent Information
- Application Number
- KR1020240093120
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2024-07-15
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2044-07-15
AI Technical Summary
Existing cosmetic compositions fail to effectively inhibit collagen-degrading enzymes induced by specific temperatures and promote collagen biosynthesis for wrinkle improvement, despite the increased demand for eco-friendly and vegan products with enhanced wrinkle improvement effects.
A cosmetic composition comprising a mixture of Metasequoia Glyptostroboides extract, Centella Asiatica extract, Ganoderma Lucidum extract, and Saussurea grandifolia extract in specific weight ratios, inhibiting collagen-degrading enzymes and promoting collagen biosynthesis.
The composition effectively inhibits collagen-degrading enzymes and enhances collagen biosynthesis, providing a significant wrinkle improvement effect.
Abstract
Description
Technology Field
[0001] The present invention relates to a cosmetic composition for wrinkle improvement comprising, as an active ingredient, a mixture of Metasequoia Glyptostroboides extract, Centella Asiatica extract, Ganoderma Lucidum extract, Fragaria Indica extract, and Saussurea grandifolia extract. More specifically, the invention relates to a cosmetic composition capable of providing a wrinkle improvement effect by including Metasequoia extract, Centella Asiatica extract, Ganoderma Lucidum extract, Fragaria Indica extract, wild strawberry extract, and Saussurea grandifolia extract as active ingredients, thereby inhibiting the activity of collagen-degrading enzymes in the skin induced by specific temperatures and promoting the collagen biosynthesis effect that is reduced by heat. Background Technology
[0002] Skin aging can be broadly classified into two types. First, natural aging, known as intrinsic aging, refers to phenomena resulting from the aging of skin cells; this process primarily proceeds from the aging of the cells themselves and is known to be associated with telomere loss. Second is photoaging, which refers to the aging phenomenon observed in skin areas such as the face, backs of the hands, and the back of the neck that have been exposed to sunlight for a long time. Ultraviolet (UV) radiation is known to be the primary cause of photoaging. UV radiation is broadly classified into UV-A (320–400 nm) and UV-B (290–320 nm); in particular, UV radiation leads to an increase in the expression of aging factors such as matrix metallopretenases (MMPs). Exposure to UV radiation triggers the expression of MMP-1, a collagenase; this increased expression then breaks down collagen, a major protein constituting the skin's dermis, or reduces its production. Therefore, inhibition of MMP-1 can delay the formation of skin wrinkles by inhibiting collagen breakdown.
[0003] Cosmetics serve the functions of maintaining human cleanliness and enhancing existing attractiveness to alter one's appearance. With modernization, there has been an increased demand for cosmetics that inhibit intrinsic aging—resulting from damage caused by external factors such as pollutants, stress, and UV rays—as well as natural aging, or for those that provide skin protection. In response, companies and research institutes are continuously developing cosmetics with whitening, wrinkle improvement and inhibition, and UV protection functions to meet consumer demand. Furthermore, recent research trends demand not only cosmetics with simple efficacy but also additional needs beyond mere aesthetic requirements, such as eco-friendly, vegan products, and upcycling.
[0004] Numerous patents have been disclosed regarding cosmetic compositions containing plant extracts that have a skin wrinkle improvement effect. Korean Registered Patent No. 10-1574248 discloses a cosmetic composition for improving skin wrinkles that includes an extract of *Reynoutria sachalinensis* as an active ingredient. Additionally, Korean Registered Patent No. 10-1693931 discloses a cosmetic composition for improving wrinkles that includes an extract of *Scytosiphon lomentaria* as an active ingredient.
[0005] Korean Registered Patent No. 10-1631924 discloses a cosmetic composition in which actin and actigenin extracted from burdock, Arctium lappa, safflower, Forsythia, etc. are encapsulated in liposomes and stabilized. The problem to be solved
[0006] The inventors, through research on natural materials that effectively improve wrinkle formation caused by specific temperatures using various natural substances, confirmed that when Metasequoia extract, Centella asiatica extract, Reishi mushroom extract, wild strawberry extract, and Sordella extract are combined in specific weight ratios, the inhibitory effect on collagen-degrading enzymes related to wrinkle formation caused by specific temperatures and the effect on collagen biosynthesis are observed compared to when they are used alone, thereby completing the present invention. The present invention aims to provide a cosmetic composition having an excellent wrinkle improvement effect by including Metasequoia extract, Centella asiatica extract, Reishi mushroom extract, wild strawberry extract, and Sordella extract in specific weight ratios. means of solving the problem
[0007] The above-mentioned objective is achieved by a cosmetic composition for wrinkle improvement comprising, as an active ingredient, a mixture of Metasequoia (Metasequoia Glyptostroboides) extract, Centella Asiatica extract, Ganoderma Lucidum extract, Fragaria Indica extract, and Saussurea grandifolia extract.
[0008] Preferably, the mixture may contain metasequoia extract, centella asiatica extract, reishi mushroom extract, wild strawberry extract, and sedge extract in a weight ratio of 1:1.5:1.5:1:1 or 1:1.5:1:1.5:1.
[0009] In addition, preferably, the mixture can improve the aging phenomenon caused by heat.
[0010] Additionally, preferably, the mixture may be included in an amount of 0.001 to 2.0 weight percent relative to the total weight of the cosmetic composition.
[0011] Additionally, preferably, the cosmetic composition may have a formulation selected from the group consisting of a solution, suspension, emulsion, paste, gel, cream, lotion, powder, pack, soap, surfactant-containing cleansing, oil, and spray. Effects of the invention
[0012] The cosmetic composition according to the present invention inhibits collagen-degrading enzymes associated with wrinkle formation due to specific temperatures and promotes collagen biosynthesis, thereby providing an excellent wrinkle improvement effect. Specific details for implementing the invention
[0013] All technical terms used in this invention, unless otherwise defined, have the following definitions and correspond to the meaning generally understood by those skilled in the art in the relevant field of this invention. Additionally, while preferred methods or samples are described herein, similar or equivalents are also included within the scope of this invention.
[0014] The term “about” means an amount, level, value, number, frequency, percentage, dimension, size, quantity, weight, or length that varies by about 30, 25, 20, 15, 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1% with respect to a reference amount, level, value, number, frequency, percentage, dimension, size, quantity, weight, or length.
[0015] Throughout this specification, unless otherwise required by the context, the terms “comprising” and “comprising” include the presented steps or components, or a group of steps or components, but any other steps or components, or steps or components
[0016] It should be understood that this implies that the group of fields is not excluded.
[0018] The present invention relates to a cosmetic composition comprising, as an active ingredient, a mixture of Metasequoia (Metasequoia Glyptostroboides) extract, Centella Asiatica extract, Ganoderma Lucidum extract, Fragaria Indica extract, and Saussurea grandifolia extract.
[0019] Metasequoia (Metasequoia Glyptostroboides) is a tree of the cypress family, also known as the water cypress. It was first described by a Japanese botanist in 1941 and is a reforestation tree primarily used for the purpose of greening parks and recreational areas.
[0020] Centella Asiatica is a perennial plant commonly found in mountains and fields in Korea, China, and Japan. It is also known as tiger grass, horse hoof grass, and clam grass. Its leaves are used medicinally for their anti-inflammatory effects and contain large amounts of triterpenoid compounds, making them widely used in the treatment of skin diseases.
[0021] Ganoderma lucidum is an annual mushroom belonging to the family Ganodermataceae of the order Polyporales that grows on deciduous trees. Also known as Bullocho or Jicho, it is distributed in temperate regions including Korea, Japan, and China. In traditional Korean medicine, it has long been used to treat inflammation such as asthma, bronchitis, and arthritis.
[0022] Fragaria indica is a perennial herb belonging to the Rosaceae family that is commonly found throughout South and East Asia. Its fruit has been used as a medicinal herb due to its excellent antipyretic and detoxifying effects on the lungs, stomach, and liver.
[0023] Saussurea grandifolia is a perennial herb belonging to the Asteraceae family that can be found in mountainous areas in Korea, Japan, and China. Its leaves and stems are edible, while its roots have been used in traditional Korean medicine for their efficacy in treating bruises and back pain.
[0024] Each of the Metasequoia extract, Centella asiatica extract, Ganoderma lucidum extract, Pteridium aquilinum extract, and Sudder extract according to the present invention may be prepared according to conventional methods known in the art, that is, under conditions of conventional temperature and pressure, using conventional solvents, but preferably, extraction is performed using (a) a solvent extraction method using a solvent selected from the group consisting of water, anhydrous or hydrated lower alcohols having 1-4 carbon atoms (e.g., methanol, ethanol, propanol, and butanol), propylene glycol, 1,3-butylene glycol, glycerin, acetone, diethyl ether, ethyl acetate, butyl acetate, dichloromethane, chloroform, hexane, and mixtures thereof; (b) a supercritical extraction method using reduced pressure and high temperature with carbon dioxide; or (c) an ultrasonic extraction method. In the present invention, a solvent extraction method using an extraction solvent was preferably used.
[0025] In the present invention, each of the Metasequoia extract, Centella asiatica extract, Ganoderma lucidum extract, Rubus coreanus extract, and Sudder extract can be obtained using one or more extraction solvents selected from the group consisting of various extraction solvents, e.g., water, anhydrous or hydrated lower alcohols having 1-4 carbon atoms (e.g., methanol, ethanol, propanol, and butanol), propylene glycol, 1,3-butylene glycol, glycerin, acetone, diethyl ether, ethyl acetate, butyl acetate, dichloromethane, chloroform, hexane, and mixtures thereof, preferably obtained using ethanol, 70% (v / v) ethanol, or water, and most preferably obtained using 70% (v / v) ethanol.
[0026] Meanwhile, it is obvious to those skilled in the art that the Metasequoia extract, Centella asiatica extract, Reishi mushroom extract, wild strawberry extract, and Sudulchwi extract of the present invention can each be obtained with substantially the same effect using other extraction solvents in addition to the extraction solvents mentioned above.
[0027] According to one embodiment of the present invention, the present invention provides a cosmetic composition that inhibits wrinkle improvement caused by a specific temperature, comprising as an active ingredient a mixture of Metasequoia extract, Centella asiatica extract, Ganoderma lucidum extract, Rubus coreanus extract, and Sudulttice extract.
[0028] According to an embodiment of the present invention, extracts of Metasequoia, Centella Asiatica, Reishi mushroom, wild strawberry, and Sedum are preferably mixed in a weight ratio of 1:0.1 to 4:0.1 to 4:0.1 to 4:1, and more preferably in a weight ratio of 1:1.5:1.5:1:1 or 1:1.5:1:1.5:1.
[0029] According to the present invention, the mixture of Metasequoia extract, Centella asiatica extract, Reishi mushroom extract, wild strawberry extract, and Sedum extract is contained in an amount of 0.001 to 10 weight% based on the total weight of the cosmetic composition, and preferably, in an amount of 0.01 to 2 weight%. If the content of the mixture is less than 0.001 weight%, it does not exhibit a wrinkle-improving effect, and if it exceeds 10 weight%, it causes discoloration and odor changes of the extracts and skin irritation, thereby limiting its use.
[0030] The cosmetic composition of the present invention may be prepared in any formulation conventionally manufactured in the art, for example, as a solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing, oil, powder foundation, emulsion foundation, wax foundation, pack, massage cream, and spray, but is not limited thereto. More specifically, it may be prepared in the form of a softening lotion, a nourishing lotion, a nourishing cream, a massage cream, an essence, an eye cream, a cleansing cream, a cleansing foam, a cleansing water, a pack, a spray, or a powder.
[0031] In the case where the formulation of the present invention is a paste, cream, or gel, animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, or zinc oxide may be used as a carrier component.
[0032] When the formulation of the present invention is a solution or an emulsion, a solvent, a solubilizing agent, or an emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol, or fatty acid ester of sorbitan.
[0033] In the case where the formulation of the present invention is a suspension, liquid diluents such as water, ethanol, or propylene glycol, ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, and polyoxyethylene sorbitan ester, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar, or tracanthese may be used as carrier components.
[0034] In the case where the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, it may additionally include a propellant such as chlorofluorohydrocarbon, propane / butane, or dimethyl ether.
[0035] In the case of a cleansing formulation containing a surfactant according to the present invention, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide ether sulfate, alkylamidobetaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, or ethoxylated glycerol fatty acid ester, etc. may be used as a carrier component.
[0036] When the cosmetic composition of the present invention is a soap, a cleansing formulation containing a surfactant, or a cleansing formulation not containing a surfactant, it may be wiped off, peeled off, or washed off with water after application to the skin. As specific examples, the soap is a liquid soap, powder soap, solid soap, and oil soap; the cleansing formulation containing a surfactant is a cleansing foam, cleansing water, cleansing towel, and cleansing pack; and the cleansing formulation not containing a surfactant is a cleansing cream, cleansing lotion, cleansing water, and cleansing gel, but is not limited to these.
[0037] When the cosmetic composition of the present invention is a soap, a cleansing formulation containing a surfactant, or a cleansing formulation not containing a surfactant, it may be wiped off, peeled off, or washed off with water after application to the skin. As specific examples, the soap is a liquid soap, powder soap, solid soap, and oil soap; the cleansing formulation containing a surfactant is a cleansing foam, cleansing water, cleansing towel, and cleansing pack; and the cleansing formulation not containing a surfactant is a cleansing cream, cleansing lotion, cleansing water, and cleansing gel, but is not limited thereto. Meanwhile, the cosmetic method of the present invention refers to any cosmetic method using the cosmetic composition of the present invention. That is, all methods known in the art using the cosmetic composition fall under the cosmetic method of the present invention. The cosmetic composition of the present invention may be used alone or in combination, or may be used in combination with other cosmetic compositions other than the present invention. In addition, the cosmetic composition according to the present invention can be used according to a conventional method of use, and the frequency of use may vary depending on the user's skin condition or preference. The present invention will be explained in more detail below through examples. These examples are solely for the purpose of explaining the present invention more specifically, and it will be obvious to those skilled in the art that the scope of the present invention is not limited by these examples according to the gist of the invention.
[0038] In the present invention, the term “extract” refers to a mixed extract obtained using Metasequoia, Centella asiatica, Ganoderma lucidum, Rubus coreanus, and Sedum sarmentosum, and means any extract of a formulation that can be formed using the extract, such as a diluted or concentrated extract, a dried product obtained by drying the extract, or a modified or purified extract.
[0040] Preparation Example 1: Preparation of Metasequoia Extract
[0041] 5 kg of Metasequoia leaves and branches were washed with clean water, dried, and then ground to a uniform size (100 mesh). They were then reflux-extracted three times for 5 hours each with a 70% (V / V) ethanol aqueous solution, cold-macerated, filtered through Whatman #4 filter paper, and used in a concentrator to prepare 0.7 kg of Arctium lappa extract.
[0043] Preparation Example 2: Preparation of Centella Asiatica Extract
[0044] 10 kg of Centella asiatica leaves and branches were washed with clean water, dried, and then ground to a uniform size (100 mesh). They were then reflux-extracted three times for 5 hours each with a 70% (V / V) ethanol aqueous solution, cold-macerated, filtered through Whatman #4 filter paper, and used in a concentrator to produce 0.4 kg of Centella asiatica extract.
[0046] Preparation Example 3: Preparation of Reishi mushroom extract
[0047] 5 kg of whole Reishi mushroom plants were dried and then ground to a uniform size (100 mesh), reflux extracted three times for 5 hours each with a 70% (V / V) ethanol aqueous solution, and then cold-macerated. After filtration with Whatman #4 filter paper, 0.6 kg of Reishi mushroom extract was prepared using a concentrator.
[0049] Preparation Example 4: Preparation of wild strawberry extract
[0050] 2 kg of whole plant (leaves, branches, and fruit) of the snakeberry plant was washed with clean water, dried, and then ground to a uniform size (100 mesh). It was then reflux-extracted three times for 5 hours each with a 70% (V / V) ethanol aqueous solution, cold-macerated, filtered through Whatman #4 filter paper, and used in a concentrator to produce 0.8 kg of snakeberry extract.
[0052] Preparation Example 5: Preparation of Sutherch Extract
[0053] 2 kg of leaves and branches of the *Suddenaria* plant were washed with clean water, dried, and then ground to a uniform size (100 mesh). They were then reflux-extracted three times for 5 hours each with a 70% (V / V) ethanol aqueous solution, cold-macerated, filtered through Whatman #4 filter paper, and used in a concentrator to produce 0.6 kg of *Suddenaria* extract.
[0055] Preparation Example 6: A mixture of Metasequoia, Centella asiatica, Reishi mushroom, wild strawberry, and Sedum.
[0056] The above Preparation Examples 1 to 5 were mixed and used in a weight ratio of 1:0.1:0.1:0.1:1 to 1:4:4:4:1. The mixing formulations are as shown in Table 1 below (unit: weight%) and are not limited to these mixing examples.
[0057] division Preparation Example 6 Preparation Example 7 Preparation Example 8 Preparation Example 9 Preparation Example 10 Preparation Example 11 Preparation Example 12 Preparation Example 13 Preparation Example 14 Preparation Example 15 Preparation Example 16 Preparation Example 17 Preparation Example 18 Preparation Example 19 Preparation Example 20 Preparation Example 21 Preparation Example 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 Preparation Example 2 0.1 0.2 0.4 0.6 0.8 1 2 3 4 1.5 1 1 1.5 1 1.5 2 Preparation Example 3 0.1 0.2 0.4 0.6 0.8 1 2 3 4 1 1.5 1 1.5 1.5 1 2 Preparation Example 4 0.1 0.2 0.4 0.6 0.8 1 2 3 4 1 1 1.5 1 1.5 1.5 1 Preparation Example 5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
[0059] Formulation example
[0060] Examples of cream formulations among cosmetics containing the extracts prepared in Preparation Examples 1 to 21 above and mixtures thereof are as shown in Tables 2 and 3 below, but are not limited to these formulation examples. More specifically, they may be prepared in the form of softening lotion, nourishing lotion, nourishing cream, massage cream, essence, eye cream, shampoo, treatment, scalp ampoule, cleansing cream, cleansing foam, cleansing water, pack, spray, or powder.
[0061] Formulation Example 1 Formulation Example 2 Formulation Example 3 Formulation Example 4 Formulation Example 5 Formulation Example 6 Formulation Example 7 Formulation Example 8 Formulation Example 9 Formulation Example 10 Formulation Example 11 Formulation Example 12 Content (weight %) Preparation Example 1 (100 ppm) Preparation Example 2 (100 ppm) Preparation Example 3 (100 ppm) Preparation Example 4 (100 ppm) Preparation Example 5 (100 ppm) Preparation Example 6 (100 ppm) Preparation Example 7 (100 ppm) Preparation Example 8 (100 ppm) Preparation Example 9 (100 ppm) Preparation Example 10 (100 ppm) Preparation Example 11 (100 ppm) Preparation Example 12 (100 ppm) 5.0 glycerin 3.0 Betaine 10.0 PEG 1500 5.0 allantoin 2.0 DL-Panthenol 0.1 E.D.T.A-2Na 0.3 Benzophenone-9-hydroxyethyl 0.02 cellulose 0.04 Sodium hyaluronate 0.1 Carboxyvinyl polymer 8.0 Triethanolamine 0.2 Octyldodecanol 0.18 Octyldodeces -16 6.0 Preservatives, fragrances, and colorings a very small amount distilled water Remaining amount total 100
[0062] Formulation Example 13 Formulation Example 14 Formulation Example 15 Formulation Example 16 Formulation Example 17 Formulation Example 18 Formulation Example 19 Formulation Example 20 Formulation Example 21 Comparative formulation example Content (weight %) Preparation Example 13 (100 ppm) Preparation Example 14 (100 ppm) Preparation Example 15 (100 ppm) Preparation Example 16 (100 ppm) Preparation Example 17 (100 ppm) Preparation Example 18 (100 ppm) Preparation Example 19 (100 ppm) Preparation Example 20 (100 ppm) Preparation Example 21 (100 ppm) - 5.0 glycerin 3.0 Betaine 10.0 PEG 1500 5.0 allantoin 2.0 DL-Panthenol 0.1 E.D.T.A-2Na 0.3 Benzophenone-9-hydroxyethyl 0.02 cellulose 0.04 Sodium hyaluronate 0.1 Carboxyvinyl polymer 8.0 Triethanolamine 0.2 Octyldodecanol 0.18 Octyldodeces -16 6.0 Preservatives, fragrances, and colorings a very small amount distilled water Remaining amount total 100
[0064] Experimental Example 1: MMP -1 production inhibition effect
[0065] Human-derived fibroblasts were cultured in DMEM medium containing 10% FBS and 1% antibiotics (100 units / ml penicillin and 100 µg / ml streptomycin). Fibroblasts from the 3rd and 4th passages were used in the experiment. Fibroblasts (1×10⁶) were placed in DMEM medium containing 1% FBS in a 96-well microplate. 6 cells / mL) were added and pre-cultured for 24 hours, and then irradiated for 10 minutes using a heat irradiator at 42°C. Afterward, the samples obtained from the preparation example were treated at various concentrations that did not show cytotoxicity, and then cultured for 2 days. After culture, the supernatant from each well was collected, and the amount of newly synthesized MMP-1 (ng / mL) was measured using an MMP-1 analysis kit (Amersham, USA). The MMP-1 production inhibition rate (%) was calculated, and the results are shown in Table 4.
[0066] division Temperature (°C) MMP-1 generation rate (%) (compared to control group) heat treatment 38 ND 40 35.48 % 42 59.72 % 44 62.35 % Preparation Example Concentration (ug / ml) MMP-1 Inhibition Rate % (Compared to Control Group) Preparation Example 1 1 ND 10 21.31 % 100 30.72 % Preparation Example 2 1 ND 10 ND 100 18.59 % Preparation Example 3 1 ND 10 12.57 % 100 32.09 % Preparation Example 4 1 ND 10 ND 100 9.40 % Preparation Example 5 1 ND 10 11.29 % 100 24.63 % Preparation Example 6 1 ND 10 12.19 % 100 25.15 % Preparation Example 7 1 ND 10 13.07 % 100 21.23 % Preparation Example 8 1 ND 10 11.19 % 100 22.36 % Preparation Example 9 1 ND 10 12.43 % 100 23.46 % Preparation Example 10 1 ND 10 11.32 % 100 25.08 % Preparation Example 11 1 5.99 % 10 15.23 % 100 23.17 % Preparation Example 12 1 6.14 % 10 14.18 % 100 24.80 % Preparation Example 13 1 6.81 % 10 16.04 % 100 25.16 % Preparation Example 14 1 3.98 % 10 12.73 % 100 21.90 % Preparation Example 15 1 9.01 % 10 17.84 % 100 23.17 % Preparation Example 16 1 4.21 % 10 13.69 % 100 19.45 % Preparation Example 17 1 3.98 % 10 12.73 % 100 21.90 % Preparation Example 18 1 15.36 % 10 32.40 % 100 40.21 % Preparation Example 19 1 7.01 % 10 15.36 % 100 25.27 % Preparation Example 20 1 13.94 % 10 29.78 % 100 40.06 % Preparation Example 21 1 8.53 % 10 14.79 % 100 23.16 %
[0068] Experimental Example 2: Collagen Biosynthesis Effect
[0069] Human skin fibroblasts were cultured in DMEM (Dulbecco's Modified Eagle's Medium, Gibco, USA) containing 10% FBS, penicillin (50 U / ml), and streptomycin (50 / ml) in a cell culture incubator maintaining constant humidity at 37°C and 5% CO2, and 1 × 10⁶ 5500 µl was dispensed into 24-well plates at a rate of cells / ml and cultured for 24 hours. Collagen type I in fibroblasts was quantified using the 'Procollagen Type I c-peptide EIAkit (TaKaRa, Japan)' via an immunosorbent assay (ELISA). For the analysis, the supernatant of the cell culture, cultured for 48 hours, was carefully collected. First, 100 µl of the 48-hour culture supernatant was added to strips coated with an antibody binding to 'Procollagen Type I cpeptide' and reacted at 37°C for 2 hours. After the reaction, unreacted substances were removed by washing three times with washing buffer; then, 100 µl of blocking buffer was added to each strip, and the mixture was reacted again at 37°C for 2 hours. After the reaction, unreacted substances were removed by washing three times with a washing buffer, and 100 µl of an Antiobody-POD conjugate solution (a solution in which POD is conjugated to another antibody that binds to 'Procollagen Type I c-peptide') was added to each sample and reacted at 37°C for 2 hours. After the reaction, unreacted substances were removed by washing three times with a washing buffer, an equal amount of substrate solution was added, and the reaction was carried out for 30 minutes. Then, a stop solution (1N H2SO4) was added to terminate the experiment. The absorbance of the strip after the experiment was completed was measured at 450 nm and compared with a collagen standard to determine the amount of newly synthesized collagen as the PICP amount. The effect of collagen synthesis is shown in Table 5.
[0070] division Temperature (°C) Collagen biosynthesis inhibition rate (%) (compared to control group) heat treatment 38 ND 40 14.38 % 42 45.09 % 44 49.12 % Preparation Example Concentration (ug / ml) Collagen biosynthesis effect % (compared to control group) Preparation Example 1 1 ND 10 ND 100 6.17 % Preparation Example 2 1 ND 10 ND 100 9.44 % Preparation Example 3 1 ND 10 ND 100 8.02 % Preparation Example 4 1 ND 10 ND 100 7.79 % Preparation Example 5 1 ND 10 5.05 % 100 16.81 % Preparation Example 6 1 ND 10 6.24 % 100 14.19 % Preparation Example 7 1 ND 10 4.04 % 100 11.52 % Preparation Example 8 1 ND 10 6.18 % 100 13.26 % Preparation Example 9 1 ND 10 7.00 % 100 11.58 % Preparation Example 10 1 ND 10 5.91 % 100 12.02 % Preparation Example 11 1 5.12 % 10 9.07 % 100 15.23 % Preparation Example 12 1 5.99 % 10 10.23 % 100 16.71 % Preparation Example 13 1 6.80 % 10 11.13 % 100 18.25 % Preparation Example 14 1 6.05 % 10 10.12 % 100 16.02 % Preparation Example 15 1 10.11 % 10 17.39 % 100 21.35 % Preparation Example 16 1 4.97 % 10 9.04 % 100 14.12 % Preparation Example 17 1 7.90 % 10 12.54 % 100 18.19 % Preparation Example 18 1 15.94 % 10 26.15 % 100 34.20 % Preparation Example 19 1 10.18 % 10 18.94 % 100 26.67 % Preparation Example 20 1 17.48 % 10 30.61 % 100 49.33 % Preparation Example 21 1 7.12 % 10 13.89 % 100 19.74 %
[0071] Through Experimental Examples 1 and 2, the optimal composition ratio of a mixed composition that helps inhibit the expression of MMP-1 related to skin aging and promote collagen biosynthesis was confirmed. Based on these results, the efficacy of the selected preparation example was verified through the following experimental examples.
[0073] Experimental Example 3: cosmetic Wrinkle improvement effect
[0074] The evaluation was conducted using the example formulation and a comparative formulation in which the active ingredient was replaced with purified water. 150 women aged 30–40 were randomly divided into 10 groups and instructed to continuously apply an appropriate amount of the creams from the example formulation and the comparative formulation to both cheeks twice daily (morning and evening) after cleansing for one month. The skin elasticity improvement effect on each subject was evaluated using a Cutometer (C+K, Germany) to determine whether elasticity had improved. The experimental results are shown in Table 6 below.
[0075] division Before use After 2 weeks of use After 4 weeks of use Formulation Example 1 18.12 20.47 21.19 Formulation Example 8 17.95 19.97 22.53 Formulation Example 10 18.33 20.74 23.97 Formulation Example 11 17.51 19.58 24.45 Formulation Example 15 17.09 23.94 28.02 Formulation Example 18 18.37 26.37 31.58 Formulation Example 19 17.68 19.55 21.36 Formulation Example 20 18.56 25.16 34.90 Formulation Example 21 17.88 19.21 22.35 Comparative formulation example 18.54 21.79 22.67
[0077] Experimental Example 3: cosmetic Moisturizing effect (improves skin barrier)
[0078] Evaluation was performed using the example formulation and a comparative formulation in which the active ingredient was replaced with purified water. Skin barrier damage was induced using a 1% aqueous solution of sodium lauryl sulfate (SLS), and 150 women aged 30-40 were randomly divided into 10 groups. They were instructed to apply an appropriate amount of the creams of the example formulation and the comparative example to the cheeks twice daily, in the morning and evening, after washing their face for one consecutive week. The moisturizing effect of the cosmetic composition of the present invention was measured. In an indoor environment with no airflow, at 25°C and 45% humidity, the example and the comparative example were applied to the upper arms of healthy women three times a day for one week. Subsequently, the transepidermal water loss (TEWL) value was measured using a TEWAMETER TM210 (C+K, Germany), and the change in TEWL value over time was calculated as △TEWL to quantify the skin's moisture content and thus measure the moisturizing effect. The test results are as shown in Table 7 below.
[0079] division Skin barrier improvement rate (%) 1D 3D 5D 7D Formulation Example 1 3.51 17.75 38.41 62.84 Formulation Example 8 3.42 15.91 35.70 66.13 Formulation Example 10 3.32 16.80 40.82 53.14 Formulation Example 11 3.37 17.18 43.28 58.71 Formulation Example 15 3.52 29.94 63.82 87.81 Formulation Example 18 3.48 30.11 65.49 90.45 Formulation Example 19 3.45 29.53 60.12 80.07 Formulation Example 20 3.56 26.75 61.28 87.33 Formulation Example 21 3.41 25.45 57.07 66.18 Comparative formulation example 2.40 13.15 34.95 48.84
Claims
Claim 1 A cosmetic composition for wrinkle improvement characterized by comprising, as active ingredients, a mixture of Metasequoia Glyptostroboides extract, Centella Asiatica extract, Ganoderma Lucidum extract, Fragaria Indica extract, and Saussurea grandifolia extract, wherein the extracts are ethanol extracts and the mixture improves heat-induced aging phenomena. Claim 2 A cosmetic composition for wrinkle improvement according to claim 1, characterized in that the mixture comprises Metasequoia extract, Centella asiatica extract, Reishi mushroom extract, wild strawberry extract, and Sudultchwi extract in a weight ratio of 1:1.5:1.5:1:1 or 1:1.5:1:1.5:
1. Claim 3 A cosmetic composition for wrinkle improvement according to claim 1, characterized in that the mixture is included in an amount of 0.001 to 10.0 weight% relative to the total weight of the cosmetic composition. Claim 4 A cosmetic composition for wrinkle improvement according to claim 1, characterized in that the cosmetic composition has a formulation selected from the group consisting of a solution, a suspension, an emulsion, a paste, a gel, a cream, a lotion, a powder, a pack, a soap, a surfactant-containing cleansing product, an oil, and a spray. Claim 5 delete
Citation Information
Patent Citations
Wrinkle-improving composition
JP2011063563A
Composition for beauty containing yellow earth
KR1020050079702A
Cosmetic Composition for Alleviating the Skin Wrinkle Comprising the Extract of Metasequoia glyptostroboides
KR1020090022368A
A fermented composite with the function of whitening, antioxidation and wrinkle care
KR1020200060675A
